Stock Events

Stock Events

Scienture 

0
90
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 2024
€1.38
Mar 2024
€7.38
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Nov 12Expected
Q2 2026
Next
-1.94
-1.74
-1.54
-1.34
Expected EPS
-1.339185
Actual EPS
N/A

Financials

-9,648.12%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
368,708.88Revenue
-35.57MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4E40.STU. It's not an investment recommendation.
NVIDIA
11
NVDA
Tesla
10
TSLA
Apple
8
AAPL
AGNC Investment
8
AGNC

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Mckesson
MCK
Mkt Cap105.2B
McKesson Corporation is a major player in the pharmaceutical distribution sector, directly competing with Trxade Health's distribution services.
Cardinal Health
CAH
Mkt Cap52.86B
Cardinal Health is a global, integrated healthcare services and products company, directly competing with Trxade Health in pharmaceutical distribution.
Henry Schein
HSIC
Mkt Cap9.46B
Henry Schein operates in the healthcare distribution sector, offering products and services that compete with Trxade Health's offerings.
GoodRx
GDRX
Mkt Cap1.12B
GoodRx offers prescription drug price comparison and discount services, competing with Trxade Health's platform for pharmacy procurement and cost savings.
Amazon
AMZN
Mkt Cap2.71T
Amazon has entered the pharmacy business with Amazon Pharmacy, competing with Trxade Health in online pharmacy services and distribution.
CVS Health
CVS
Mkt Cap110.58B
CVS Health operates as a health services and innovation company, including pharmacy services that compete with Trxade Health's offerings.

About

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Show More
CEO
Shankar Hariharan
Employees
9
Country
United States
ISIN
US80880X2036
WKN
000A42NTH

Listings

STU
DE
4E4.STU
STU
DE
4E40.STU
XNAS
US
SCNX
F
DE
4E4.F

0 Comments

Share your thoughts

FAQs

What is Scienture stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Scienture stocks are traded under the ticker 4E40.STU.
When is the next Scienture earnings date?▼
Scienture is going to release the next earnings report on November 12, 2026.
What were Scienture earnings last quarter?▼
4E40.STU earnings for the last quarter are -1.51 EUR per share, whereas the estimation was -1.94 EUR resulting in a +22.22% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Scienture revenue for the last year?▼
Scienture revenue for the last year amounts to 368,708.88 EUR.
What is Scienture net income for the last year?▼
4E40.STU net income for the last year is -35.57M EUR.
Does Scienture pay dividends?▼
Yes, 4E40.STU dividends are paid quarterly. The last dividend per share was 1.38 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Scienture have?▼
As of October 8, 2026, the company has 9 employees.
In which sector is Scienture located?▼
Scienture operates in the Health & Wellness sector.
When did Scienture complete a stock split?▼
Scienture has not had any recent stock splits.
Where is Scienture headquartered?▼
Scienture is headquartered in COMMACK, United States.